Chemclin Diagnostics Co. Ltd. A (688468) - Total Liabilities

Latest as of March 2026: CN¥344.10 Million CNY ≈ $50.35 Million USD

Based on the latest financial reports, Chemclin Diagnostics Co. Ltd. A (688468) has total liabilities worth CN¥344.10 Million CNY (≈ $50.35 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Chemclin Diagnostics Co. Ltd. A's assets to evaluate the company's liquid asset resilience ratio.

Chemclin Diagnostics Co. Ltd. A - Total Liabilities Trend (2017–2025)

This chart illustrates how Chemclin Diagnostics Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688468 total assets.

Chemclin Diagnostics Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Chemclin Diagnostics Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
American Integrity Insurance Group, Inc. NYSE:AII	USA	$888.05 Million
Kolon Plastics KO:138490	Korea	₩80.25 Billion
American Exceptionalism Acquisition Corp. A NYSE:AEXA	USA	$20.73 Million
Siward Crystal Technology Co Ltd TW:2484	Taiwan	NT$901.23 Million
Xinjiang Haoyuan Natural Gas Co Ltd SHE:002700	China	CN¥216.21 Million
Beijing ZEHO Waterfront Ecological Environment Treatment Co Ltd SHG:605069	China	CN¥2.27 Billion
YC Inox Co Ltd TW:2034	Taiwan	NT$12.61 Billion
XMax Inc. NASDAQ:XWIN	USA	$4.70 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Chemclin Diagnostics Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Chemclin Diagnostics Co. Ltd. A to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chemclin Diagnostics Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chemclin Diagnostics Co. Ltd. A (2017–2025)

The table below shows the annual total liabilities of Chemclin Diagnostics Co. Ltd. A from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥350.05 Million ≈ $51.22 Million	-15.82%
2024-12-31	CN¥415.85 Million ≈ $60.85 Million	-3.68%
2023-12-31	CN¥431.76 Million ≈ $63.18 Million	+105.02%
2022-12-31	CN¥210.59 Million ≈ $30.82 Million	+38.33%
2021-12-31	CN¥152.23 Million ≈ $22.28 Million	+27.43%
2020-12-31	CN¥119.46 Million ≈ $17.48 Million	-5.50%
2019-12-31	CN¥126.42 Million ≈ $18.50 Million	+56.33%
2018-12-31	CN¥80.87 Million ≈ $11.83 Million	+22.24%
2017-12-31	CN¥66.15 Million ≈ $9.68 Million	--

About Chemclin Diagnostics Co. Ltd. A

SHG:688468 China Diagnostics & Research

Market Cap

$386.21 Million

CN¥2.64 Billion CNY

Market Cap Rank

#13711 Global

#4132 in China

Share Price

CN¥6.58

Change (1 day)

+0.61%

52-Week Range

CN¥5.55 - CN¥8.40

All Time High

CN¥27.99